Madrigal Pharmaceuticals
MDGL
#1581
Rank
A$19.73 B
Marketcap
A$868.78
Share price
-1.52%
Change (1 day)
74.60%
Change (1 year)

Madrigal Pharmaceuticals (MDGL) - Cash on Hand

Cash on Hand as of September 2025 : A$1.67 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company has A$1.67 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Madrigal Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.48 B59.99%
2023-12-31A$0.93 B76.54%
2022-12-31A$0.52 B41.38%
2021-12-31A$0.37 B0.91%
2020-12-31A$0.36 B-41.07%
2019-12-31A$0.62 B-8.67%
2018-12-31A$0.68 B179.89%
2017-12-31A$0.24 B336.64%
2016-12-31A$56.18 M13265.19%
2015-12-31A$0.42 M-99.65%
2014-12-31A$0.11 B16.39%
2013-12-31A$0.10 B5.94%
2012-12-31A$96.8 M149.86%
2011-12-31A$38.74 M-22.79%
2010-12-31A$50.18 M2.09%
2009-12-31A$49.15 M-52.86%
2008-12-31A$0.10 B-21.13%
2007-12-31A$0.13 B122.56%
2006-12-31A$59.39 M-29.96%
2005-12-31A$84.81 M-47.48%
2004-12-31A$0.16 B57.47%
2003-12-31A$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Onconova Therapeutics
ONTX
A$24.66 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$0.62 B-62.59%๐Ÿ‡บ๐Ÿ‡ธ USA